logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type [see all tables in this series...]

Part (iii) All clients with cocaine as primary drug type: number of episodes reporting the stated drug as secondary

CountryOpioidsCocaineOther stimulantsHypnotics/sedativesHallucinogensVolatile substancesCannabisAlcoholOthers
Czech Republic002000004
Denmark31014168264158167845
Germany519264786418723715113979131
Ireland48812447411841781
Greece271184150493181
Spain742101418571214195815796019808
France27047140502233712241662
Italy12276658419314620253719478975
Cyprus12125040347124
Latvia100000002
Luxembourg260662020262
Malta220221060346100
Netherlands3661819839915919082242
Austria57163231416149401
Slovakia203000210
Finland001000120
Sweden5123810111669
United Kingdom2492675127341966153404334216453
Total584734754905162576679144111560350960

Notes:

 Data on secondary drug use are only collected among all treatment clients and not separately for new treatment clients. 

 ‘Opioids’ include: heroin, methadone, other opioids; ‘Cocaine’ includes: cocaine HCl, crack cocaine; ‘Stimulants’ include: amphetamines, MDMA and derivates, other stimulants: ‘Cannabis’ can include herb or resin. For each client up to four secondary drugs can be reported. 

 A number of the clients report using the same drug both as primary and secondary drug, particularly for cannabis. Clients may report using different sub-types of the same substance, as defined in the TDI Protocol for the drugs categories. 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007.  

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008